Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Squamous Cell × Injections × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 19 Myelodysplastic Syndromes 7 Carcinoma, Non-Small-Cell Lung 7 Leukemia, Myelomonocytic, Chronic 6 Advanced Solid Tumor 6 Triple Negative Breast Neoplasms 4 Neoplasms 4 Breast Neoplasms 4 Advanced Solid Tumour 4 Advanced Solid Tumors 4 Solid Tumor 3 Myeloproliferative Disorders 3 Sarcoma 2 Recurrence 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2 Multiple Myeloma 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Monocytic, Acute 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Biliary Tract Neoplasms 2 Uterine Cervical Neoplasms 1 Tuberous Sclerosis 1 Thrombocythemia, Essential 1

Interventions

pembrolizumab 11 Cisplatin 9 Carboplatin 9 Paclitaxel 6 Radiotherapy, Intensity-Modulated 5 Radiotherapy 4 cemiplimab 3 Radiation 3 Docetaxel 3 Blood Specimen Collection 3 alpha-2'-deoxythioguanosine 2 Taxes 2 Standard of Care 2 Nivolumab 2 Drug Therapy 2 toripalimab 1 regorafenib 1 olaparib 1 lenvatinib 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 bavituximab 1 avelumab 1 atezolizumab 1 aldesleukin 1 aflibercept 1 Vitamin D 1 Vinorelbine 1 Tumor Burden 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡